minoxidil has been researched along with Scalp Dermatoses in 24 studies
Minoxidil: A potent direct-acting peripheral vasodilator (VASODILATOR AGENTS) that reduces peripheral resistance and produces a fall in BLOOD PRESSURE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p371)
minoxidil : A pyrimidine N-oxide that is pyrimidine-2,4-diamine 3-oxide substituted by a piperidin-1-yl group at position 6.
Scalp Dermatoses: Skin diseases involving the SCALP.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 32-week, double-blind, placebo-controlled trial was conducted in 10 European centers to assess the efficacy and safety of 2% topical minoxidil solution for the treatment of androgenetic alopecia in women." | 9.07 | Use of topical minoxidil therapy for androgenetic alopecia in women. ( Jacobs, JP; Szpunar, CA; Warner, ML, 1993) |
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 7.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "We report a 24-year-old woman with androgenetic alopecia who became sensitized to topical minoxidil following use of an extemporaneous preparation of minoxidil 4% with retinoic acid in a propylene glycol base." | 7.71 | Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. ( Mallari, RS; Sinclair, RD; Tate, B, 2002) |
| "Treatment with minoxidil can induce an increase in hair density and hair thickness,whereas treatment with alfatradiol results in deceleration or stabilization of hair loss." | 6.73 | Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. ( Blume-Peytavi, U; Ellwanger, U; Garcia Bartels, N; Hoffmann, R; Krisp, A; Kunte, C, 2007) |
| "A 32-week, double-blind, placebo-controlled trial was conducted in 10 European centers to assess the efficacy and safety of 2% topical minoxidil solution for the treatment of androgenetic alopecia in women." | 5.07 | Use of topical minoxidil therapy for androgenetic alopecia in women. ( Jacobs, JP; Szpunar, CA; Warner, ML, 1993) |
| "Topical 2,4-diamino-6-piperidinopyrimidine-3-oxide (minoxidil) solution has been widely used for the treatment of androgenetic alopecia for over 15 years now and the substance is currently approved for this indication in 2% and 5% formulation." | 3.73 | Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution. ( Allam, JP; Bieber, T; Hagemann, T; Novak, N; Schlütter-Böhmer, B, 2005) |
| "We report a 24-year-old woman with androgenetic alopecia who became sensitized to topical minoxidil following use of an extemporaneous preparation of minoxidil 4% with retinoic acid in a propylene glycol base." | 3.71 | Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia. ( Mallari, RS; Sinclair, RD; Tate, B, 2002) |
| "Treatment with minoxidil can induce an increase in hair density and hair thickness,whereas treatment with alfatradiol results in deceleration or stabilization of hair loss." | 2.73 | Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women. ( Blume-Peytavi, U; Ellwanger, U; Garcia Bartels, N; Hoffmann, R; Krisp, A; Kunte, C, 2007) |
| "Thus, in patients with cancer, alopecia can be iatrogenic (chemotherapies, endocrine therapies, targeted therapies, immunotherapies, radiotherapy, surgery) or directly the consequence of the disease itself (malnutrition, scalp metastases, paraneoplastic syndromes)." | 2.72 | [Alopecia and cancers: From basics to clinical practice]. ( Baussard, L; Fiteni, F; Guichard, A; Le Vigouroux, S; Quesada, S, 2021) |
| "Excessive daily hair loss (effluvium) may be physiological, as in the postpartum state, or pathological, due for example to thyroid disturbances, drug effects, iron deficiency, or syphilis." | 2.53 | The Diagnosis and Treatment of Hair and Scalp Diseases. ( Blume-Peytavi, U; Fischer, TW; Wolff, H, 2016) |
| "To fully understand hair loss during childhood, a basic comprehension of normal hair growth is necessary." | 2.52 | Hair loss in children. ( Alves, R; Grimalt, R, 2015) |
| "In men it produces male pattern hair loss with bitemporal recession and vertex baldness." | 2.47 | Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness. ( Dawson, TL; Patel, M; Perez, A; Rufaut, NW; Sinclair, R; Yazdabadi, A; Yip, L, 2011) |
| "Three of these women were premenopausal." | 1.33 | Frontal fibrosing alopecia: a survey in 16 patients. ( Camacho Martínez, F; Moreno-Ramírez, D, 2005) |
| "Although androgenetic alopecia (common baldness) is the most frequently occurring type of hair loss, hair loss can result from a variety of local and systemic conditions." | 1.29 | Alopecia: diagnosis and management. ( Nielson, TA; Reichel, M, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (20.83) | 18.7374 |
| 1990's | 3 (12.50) | 18.2507 |
| 2000's | 7 (29.17) | 29.6817 |
| 2010's | 8 (33.33) | 24.3611 |
| 2020's | 1 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Quesada, S | 1 |
| Guichard, A | 1 |
| Le Vigouroux, S | 1 |
| Baussard, L | 1 |
| Fiteni, F | 1 |
| Miguel-Gómez, L | 1 |
| Rodrigues-Barata, AR | 1 |
| Molina-Ruiz, A | 1 |
| Martorell-Calatayud, A | 1 |
| Fernández-Crehuet, P | 1 |
| Grimalt, R | 2 |
| Barco, D | 1 |
| Arias-Santiago, S | 1 |
| Serrano-Falcón, C | 1 |
| Camacho, FM | 1 |
| Saceda-Corralo, D | 1 |
| Jaén-Olasolo, P | 1 |
| Vañó-Galván, S | 1 |
| Napolitano, M | 1 |
| Cantelli, M | 1 |
| Vastarella, M | 1 |
| Nappa, P | 1 |
| Fabbrocini, G | 1 |
| Patruno, C | 1 |
| Chen, W | 1 |
| Kigitsidou, E | 1 |
| Prucha, H | 1 |
| Ring, J | 1 |
| Andres, C | 1 |
| Alves, R | 1 |
| Emre, S | 1 |
| Metin, A | 1 |
| Caykoylu, A | 1 |
| Akoglu, G | 1 |
| Ceylan, GG | 1 |
| Oztekin, A | 1 |
| Col, ES | 1 |
| Wolff, H | 1 |
| Fischer, TW | 1 |
| Blume-Peytavi, U | 2 |
| Guarneri, C | 1 |
| Cannavò, SP | 1 |
| Sinclair, R | 1 |
| Patel, M | 1 |
| Dawson, TL | 1 |
| Yazdabadi, A | 1 |
| Yip, L | 1 |
| Perez, A | 1 |
| Rufaut, NW | 1 |
| Sinclair, RD | 1 |
| Mallari, RS | 1 |
| Tate, B | 1 |
| Hagemann, T | 1 |
| Schlütter-Böhmer, B | 1 |
| Allam, JP | 1 |
| Bieber, T | 1 |
| Novak, N | 1 |
| Moreno-Ramírez, D | 1 |
| Camacho Martínez, F | 1 |
| Kunte, C | 1 |
| Krisp, A | 1 |
| Garcia Bartels, N | 1 |
| Ellwanger, U | 1 |
| Hoffmann, R | 1 |
| Nielson, TA | 1 |
| Reichel, M | 1 |
| Jacobs, JP | 1 |
| Szpunar, CA | 1 |
| Warner, ML | 1 |
| Fisher, AA | 1 |
| Scheman, AJ | 1 |
| West, DP | 1 |
| Hordinksy, MK | 1 |
| Osburn, AH | 1 |
| West, LE | 1 |
| Malakar, S | 1 |
| Dhar, S | 1 |
| Suzuki, K | 1 |
| Suzuki, M | 1 |
| Akamatsu, H | 1 |
| Matsungaga, K | 1 |
| Degreef, H | 1 |
| Hendrickx, I | 1 |
| Dooms-Goossens, A | 1 |
| Baral, J | 1 |
| van der Willigen, AH | 1 |
| Dutrée-Meulenberg, RO | 1 |
| Stolz, E | 1 |
| Geursen-Reitsma, AM | 1 |
| van Joost, T | 1 |
| Valsecchi, R | 1 |
| Cainelli, T | 1 |
| Tosti, A | 1 |
| Bardazzi, F | 1 |
| De Padova, MP | 1 |
| Caponeri, GM | 1 |
| Melino, M | 1 |
| Veronesi, S | 1 |
4 reviews available for minoxidil and Scalp Dermatoses
| Article | Year |
|---|---|
[Alopecia and cancers: From basics to clinical practice].
Topics: Alopecia; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Hair; Hair Follicle; Humans; | 2021 |
Hair loss in children.
Topics: Adrenal Cortex Hormones; Alopecia; Alopecia Areata; Child; Child, Preschool; Diagnosis, Differential | 2015 |
The Diagnosis and Treatment of Hair and Scalp Diseases.
Topics: Alopecia; Combined Modality Therapy; Dermatologic Agents; Diagnosis, Differential; Evidence-Based Me | 2016 |
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Cosmetic Techniques; Female; Finasteri | 2011 |
3 trials available for minoxidil and Scalp Dermatoses
| Article | Year |
|---|---|
Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women.
Topics: Administration, Topical; Alopecia; Drug Eruptions; Estradiol; Female; Germany; Hair; Humans; Middle | 2007 |
Use of topical minoxidil therapy for androgenetic alopecia in women.
Topics: Administration, Cutaneous; Adolescent; Adult; Age Factors; Alopecia; Dermatitis, Contact; Double-Bli | 1993 |
Topical minoxidil sensitization in androgenic alopecia.
Topics: Administration, Topical; Alopecia; Clinical Trials as Topic; Double-Blind Method; Drug Eruptions; Hu | 1987 |
17 other studies available for minoxidil and Scalp Dermatoses
| Article | Year |
|---|---|
Folliculitis decalvans: Effectiveness of therapies and prognostic factors in a multicenter series of 60 patients with long-term follow-up.
Topics: Adrenal Cortex Hormones; Alopecia; Anti-Bacterial Agents; Cicatrix; Cohort Studies; Combined Modalit | 2018 |
Allergic contact dermatitis probably caused by latanoprost during treatment for alopecia areata.
Topics: Administration, Cutaneous; Alopecia Areata; Dermatitis, Allergic Contact; Facial Dermatoses; Female; | 2019 |
Male frontal fibrosing alopecia with generalised hair loss.
Topics: Aged; Alopecia; Anti-Inflammatory Agents; Axilla; Dermatologic Agents; Extremities; Eyebrows; Fibros | 2014 |
Clinical characteristics and HLA alleles of a family with simultaneously occurring alopecia areata.
Topics: Adrenal Cortex Hormones; Adult; Alopecia Areata; Anxiety; Child; Compulsive Personality Disorder; Cr | 2016 |
Erosive pustular dermatosis of the scalp from topical minoxidil 5% solution.
Topics: Aged; Alopecia; Dermatologic Agents; Drug Eruptions; Female; Humans; Minoxidil; Scalp; Scalp Dermato | 2013 |
Sensitization to saw palmetto and minoxidil in separate topical extemporaneous treatments for androgenetic alopecia.
Topics: Administration, Topical; Adult; Alopecia; Dermatitis, Allergic Contact; Female; Humans; Minoxidil; P | 2002 |
Positive lymphocyte transformation test in a patient with allergic contact dermatitis of the scalp after short-term use of topical minoxidil solution.
Topics: Administration, Topical; Aged; Alopecia; Dermatitis, Allergic Contact; Drug Eruptions; Female; Human | 2005 |
Frontal fibrosing alopecia: a survey in 16 patients.
Topics: Aged; Alopecia; Diagnosis, Differential; Disease Progression; Enzyme Inhibitors; Eyebrows; Female; F | 2005 |
Alopecia: diagnosis and management.
Topics: Alopecia; Dermatomycoses; Female; Humans; Lupus Erythematosus, Discoid; Lupus Erythematosus, Systemi | 1995 |
Unusual acute, nonallergic eruptions of the scalp from combined use of minoxidil and retinoic acid.
Topics: Drug Eruptions; Erythema; Granuloma; Humans; Male; Middle Aged; Minoxidil; Scalp Dermatoses; Tretino | 1993 |
Alternative formulation for patients with contact reactions to topical 2% and 5% minoxidil vehicle ingredients.
Topics: Administration, Topical; Alopecia; Chemistry, Pharmaceutical; Dermatitis, Allergic Contact; Dose-Res | 2000 |
Leucoderma associated with the use of topical minoxidil: a report of two cases.
Topics: Administration, Cutaneous; Adult; Diagnosis, Differential; Humans; Hypopigmentation; Male; Minoxidil | 2000 |
Allergic contact dermatitis from minoxidil: study of the cross-reaction to minoxidil.
Topics: Cross Reactions; Dermatitis, Allergic Contact; Diagnosis, Differential; Hair Preparations; Humans; M | 2002 |
Allergic contact dermatitis to minoxidil.
Topics: Adult; Alopecia; Drug Eruptions; Female; Humans; Minoxidil; Patch Tests; Scalp Dermatoses | 1985 |
Scalp comedones after topical minoxidil.
Topics: Acne Vulgaris; Alopecia; Humans; Male; Minoxidil; Scalp Dermatoses | 1985 |
Allergic contact dermatitis from minoxidil.
Topics: Adult; Alopecia; Drug Eruptions; Facial Dermatoses; Humans; Male; Minoxidil; Patch Tests; Scalp Derm | 1987 |
Contact dermatitis to minoxidil.
Topics: Adult; Alopecia; Dermatitis, Contact; Facial Dermatoses; Humans; Male; Minoxidil; Scalp Dermatoses | 1985 |